Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma (Q46060437)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Postoperative serum osteopontin level is a novel monitor for treatment response and tumor recurrence after resection of hepatitis B-related hepatocellular carcinoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

author name string

Chuang Zhou

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Hai-Jun Zhou

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Xiao-Fei Zhang

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Li-Li Lou

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Qing-Hai Ye

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Yan Zheng

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Ji Wang

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Hai-Tao Zhu

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Qiong-Zhu Dong

9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Hu-Liang Jia

10

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Wen-Wei Zhu

11

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Lei Guo

12

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Yue Zhao

13

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Dong-Mei Gao

14

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Lun-Xiu Qin

15

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

publication date

1 December 2012

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Annals of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

20

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

929-937

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Major achievements in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Hepatocellular carcinoma: current management and perspectives for the future

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Gene-expression signature of vascular invasion in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Role of the metastasis-promoting protein osteopontin in the tumour microenvironment

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Expression and prognostic significance of osteopontin and caspase-3 in hepatocellular carcinoma patients after curative resection

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Prognostic value of interleukin 2 and interleukin 15 in peritumoral hepatic tissues for patients with hepatitis B-related hepatocellular carcinoma after curative resection

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Prognostic significance of osteopontin in hepatitis B virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Identification of osteopontin as a novel marker for early hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Reduction of elevated plasma osteopontin levels with resection of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-012-2749-9

21 January 2018

Identifiers

10.1245/S10434-012-2749-9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/23203407

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46060437&oldid=2207584646"